Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Ovid Therapeutics
(1OT.F) Q2 2025
Earnings
1OT.F
May 13
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.1
0
0.11
Details
Expected EPS
-0.12288931671
Actual EPS
-0.12510820000000003
Surprise EPS
-0
Surprise Percent
-1.81%
Description
Ovid Therapeutics (1OT.F) has reported earnings of -0.12510820000000003 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login